Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Heikki Huhta, Jukka Melkko, Teijo Kuopio, Tuomo J. Karttunen & Olli Helminen. (2022) Risk of progression in Barrett’s esophagus based on diagnoses of general and gastrointestinal pathologists. A retrospective case-control study from Northern and Central Finland. Scandinavian Journal of Gastroenterology 57:9, pages 1024-1029.
Read now
Read now
Melania Scarpa, Matteo Fassan, Andromachi Kotsafti, Stefano Realdon, Luigi Dall’Olmo, Tiziana Morbin, Francesco Cavallin, Luca Saadeh, Matteo Cagol, Rita Alfieri, Carlo Castoro, Massimo Rugge, Ignazio Castagliuolo & Marco Scarpa. (2019) CD80 expression promotes immune surveillance in Barrett’s metaplasia. OncoImmunology 8:10.
Read now
Read now
Mark Van Blankenstein, Caspar W. N. Looman, Michelle E. Kruijshaar, Peter D. Siersema, Ernst J. Kuipers & Peter Bytzer. (2007) Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data. Scandinavian Journal of Gastroenterology 42:3, pages 308-317.
Read now
Read now
Piet N. Post, Peter D. Siersema & Herman Van Dekken. (2007) Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: A nation-wide registry of pathology reports. Scandinavian Journal of Gastroenterology 42:1, pages 17-22.
Read now
Read now
Rudy R. Sital, Johannes G. Kusters, Felix W. M. De Rooij, Ernst J. Kuipers & Peter D. Siersema. (2006) Bile acids and Barrett's oesophagus: A sine qua non or coincidence?. Scandinavian Journal of Gastroenterology 41:sup243, pages 11-17.
Read now
Read now
Articles from other publishers (78)
Leonardo H Eusebi, Andrea Telese, Giovanna G Cirota, Rehan Haidry, R Maurizio Zagari, Franco Bazzoli & Alexander C Ford. (2022) Effect of gastro‐esophageal reflux symptoms on the risk of Barrett's esophagus: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 37:8, pages 1507-1516.
Crossref
Crossref
Hamza Chettouh, Oliver Mowforth, Núria Galeano-Dalmau, Navya Bezawada, Caryn Ross-Innes, Shona MacRae, Irene Debiram-Beecham, Maria O’Donovan & Rebecca C Fitzgerald. (2018) Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens. Gut 67:11, pages 1942-1949.
Crossref
Crossref
Prateek Kinra, Gaurav P.S. Gahlot, Rajni Yadav, Vandana Baloda, Govind K. Makharia, Siddhartha Datta Gupta & Prasenjit Das. (2018) Histological assessment & use of immunohistochemical markers for detection of dysplasia in Barrett’s esophageal mucosa. Pathology - Research and Practice 214:7, pages 993-999.
Crossref
Crossref
Rajesh Krishnamoorthi, Siddharth Singh, Karthik Ragunathan, Kavel Visrodia, Kenneth K. Wang, David A. Katzka & Prasad G. Iyer. (2018) Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 16:7, pages 1046-1055.e8.
Crossref
Crossref
Margreet Putten, Brian T Johnston, Liam J Murray, Anna T Gavin, Damian T McManus, Shivaram Bhat, Richard C Turkington & Helen G Coleman. (2018) ‘Missed’ oesophageal adenocarcinoma and high‐grade dysplasia in Barrett's oesophagus patients: A large population‐based study. United European Gastroenterology Journal 6:4, pages 519-528.
Crossref
Crossref
Gemma Maddalo, Matteo Fassan, Romilda Cardin, Marika Piciocchi, Filippo Marafatto, Massimo Rugge, Giovanni Zaninotto, Caterina Pozzan, Carlo Castoro, Alberto Ruol, Alessandra Biasiolo & Fabio Farinati. (2018) Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer. Journal of Clinical Gastroenterology 52:5, pages 401-406.
Crossref
Crossref
Fatemeh G. Amlashi, Xuemei Wang, Raquel E. Davila, Dipen M. Maru, Manoop S. Bhutani, Jeffrey H. Lee, Brian R. Weston, Dilsa Mizrak Kaya, Maria Vassilakopoulou, Kazuto Harada, Mariela A. Blum Murphy, David C. Rice, Wayne L. Hofstetter, Marta Davila, Quynh-nhu Nguyen & Jaffer A. Ajani. (2018) Barrett’s Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma. Oncology 95:2, pages 81-90.
Crossref
Crossref
Vincent T. Janmaat, Sophie H. van Olphen, Katharina E. Biermann, Leendert H. J. Looijenga, Marco B. Bruno & Manon C. W. Spaander. (2017) Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis. PLOS ONE 12:10, pages e0186305.
Crossref
Crossref
Rita Abdelmessih, Christopher D. Packey & Garrett Lawlor. (2016) Endoscopy in the Elderly: a Cautionary Approach, When to Stop. Current Treatment Options in Gastroenterology 14:3, pages 305-314.
Crossref
Crossref
S. M. Brankley, K. C. Halling, S. M. Jenkins, M. R. Timmer, P. G. Iyer, T. C. Smyrk, E. G. Barr Fritcher, J. S. Voss, B. R. Kipp, M. B. Campion, L. S. Lutzke, D. M. Minot & K. K. Wang. (2016) Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma. Diseases of the Esophagus 29:6, pages 513-519.
Crossref
Crossref
Kavel Visrodia, Siddharth Singh, Rajesh Krishnamoorthi, David A. Ahlquist, Kenneth K. Wang, Prasad G. Iyer & David A. Katzka. (2016) Magnitude of Missed Esophageal Adenocarcinoma After Barrett’s Esophagus Diagnosis: A Systematic Review and Meta-analysis. Gastroenterology 150:3, pages 599-607.e7.
Crossref
Crossref
Yao Qiao, Ayaz Hyder, Sandy J Bae, Wasifa Zarin, Tyler J O'Neill, Norman E Marcon, Lincoln Stein & Hla-Hla Thein. (2015) Surveillance in Patients With Barrett's Esophagus for Early Detection of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis. Clinical and Translational Gastroenterology 6:12, pages e131.
Crossref
Crossref
Brian J. Reid, Thomas G. Paulson & Xiaohong Li. (2015) Genetic Insights in Barrett’s Esophagus and Esophageal Adenocarcinoma. Gastroenterology 149:5, pages 1142-1152.e3.
Crossref
Crossref
Itay Amir, Fred M. Konikoff, Michal Oppenheim, Uri Gophna & Elizabeth E. Half. (2014) Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors. Environmental Microbiology 16:9, pages 2905-2914.
Crossref
Crossref
Siddharth Singh, Palaniappan Manickam, Anita V. Amin, Niharika Samala, Leo J. Schouten, Prasad G. Iyer & Tusar K. Desai. (2014) Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis. Gastrointestinal Endoscopy 79:6, pages 897-909.e4.
Crossref
Crossref
Belgin Alasehirli, Elif Oğuz, Ebru Oksuzler, Irfan Koruk, Serdar Oztuzcu, Esma Ozkara, Metin Karakok, Ayse Binnur Erbagcı & Abdullah Tuncay Demiryurek. (2014) Investigation of intercellular adhesion molecules (ICAMs) gene expressions in patients with Barrett's esophagus. Tumor Biology 35:5, pages 4907-4912.
Crossref
Crossref
L. Max Almond & Hugh Barr. (2013) Management controversies in Barrett’s oesophagus. Journal of Gastroenterology 49:2, pages 195-205.
Crossref
Crossref
Pieter Jan F de Jonge, Mark van Blankenstein, William M Grady & Ernst J Kuipers. (2014) Barrett's oesophagus: epidemiology, cancer risk and implications for management. Gut 63:1, pages 191-202.
Crossref
Crossref
Rebecca C Fitzgerald, Massimiliano di Pietro, Krish Ragunath, Yeng Ang, Jin-Yong Kang, Peter Watson, Nigel Trudgill, Praful Patel, Philip V Kaye, Scott Sanders, Maria O'Donovan, Elizabeth Bird-Lieberman, Pradeep Bhandari, Janusz A Jankowski, Stephen Attwood, Simon L Parsons, Duncan Loft, Jesper Lagergren, Paul Moayyedi, Georgios Lyratzopoulos & John de Caestecker. (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 63:1, pages 7-42.
Crossref
Crossref
Zhe Jin, Liang Wang, Yuan Zhang, Yulan Cheng, Yan Gao, Xianling Feng, Ming Dong, Ziyi Cao, Si Chen, Huimin Yu, Zhenfu Zhao, Xiaojing Zhang, Jie Liu, Yuriko Mori, Xinmin Fan & Stephen J. Meltzer. (2013) MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma. Scientific Reports 3:1.
Crossref
Crossref
Ş. Çoban, N. Örmeci, B. Savaş, F. Ekiz, A. Ensari, I. Kuzu & M. Palabıyıkoğlu. (2013) Evaluation of Barrett's esophagus with CK7, CK20, p53, Ki67, and COX2 expressions using chromoendoscopical examination. Diseases of the Esophagus 26:2, pages 189-196.
Crossref
Crossref
Eric M. Pauli, Steve J. Schomisch, Joseph P. Furlan, Andrea S. Marks, Amitabh Chak, Richard H. Lash, Jeffrey L. Ponsky & Jeffrey M. Marks. (2012) Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model. Surgical Endoscopy 26:12, pages 3500-3508.
Crossref
Crossref
George C. Mayne, Tim Bright, Damian J. Hussey & David I. Watson. (2012) Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?. ANZ Journal of Surgery 82:9, pages 592-598.
Crossref
Crossref
P. Bus, P. D. Siersema & J. W. P. M. van Baal. (2012) Cell culture models for studying the development of Barrett’s esophagus: a systematic review. Cellular Oncology 35:3, pages 149-161.
Crossref
Crossref
Florine Kastelein, Manon C.W. Spaander, Katharina Biermann, Ewout W. Steyerberg, Ernst J. Kuipers & Marco J. Bruno. (2011) Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus. Gastroenterology 141:6, pages 2000-2008.
Crossref
Crossref
Frederik Hvid-Jensen, Lars Pedersen, Asbjørn Mohr Drewes, Henrik Toft Sørensen & Peter Funch-Jensen. (2011) Incidence of Adenocarcinoma among Patients with Barrett's Esophagus. New England Journal of Medicine 365:15, pages 1375-1383.
Crossref
Crossref
Henry D. Appelman, Asad Umar, Roy C. Orlando, Stephen J. Sontag, Sanjay Nandurkar, Hala El-Zimaity, Angel Lanas, Paolo Parise, René Lambert & Helen M. Shields. (2011) Barrett's esophagus: natural history. Annals of the New York Academy of Sciences 1232:1, pages 292-308.
Crossref
Crossref
Helen M. Shields, Gerardo Nardone, Jingjing Zhao, Wen Wang, Zheng Xing, Dianchun Fang, Brian C. Jacobson, Yvonne Romero, Katerina Dvorak, Aaron Goldman, Carlos A. Pellegrini, Elizabeth L. Wiley, David A. Peura, Roger P. Tatum & Thomas G. Schnell. (2011) Barrett's esophagus: prevalence and incidence of adenocarcinomas. Annals of the New York Academy of Sciences 1232:1, pages 230-247.
Crossref
Crossref
Paolo Parise, Riccardo Rosati, Edoardo Savarino, Andrea Locatelli, Martina Ceolin, Kulwinder S. Dua, Roger P. Tatum, Italo Braghetto, C. Prakash Gyawali, Reza A. Hejazi, Richard W. McCallum, Irene Sarosiek, Luigi Bonavina, Eelco B. Wassenaar, Carlos A. Pellegrini, Brian C. Jacobson, Cheri L. Canon, Adolfo Badaloni & Gianmattia del Genio. (2011) Barrett's esophagus: surgical treatments. Annals of the New York Academy of Sciences 1232:1, pages 175-195.
Crossref
Crossref
S. Bhat, H. G. Coleman, F. Yousef, B. T. Johnston, D. T. McManus, A. T. Gavin & L. J. Murray. (2011) Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study. JNCI Journal of the National Cancer Institute 103:13, pages 1049-1057.
Crossref
Crossref
C M den Hoed, M van Blankenstein, J Dees & E J Kuipers. (2011) The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma. British Journal of Cancer 105:2, pages 200-205.
Crossref
Crossref
M Sikkema, C W N Looman, E W Steyerberg, M Kerkhof, F Kastelein, H van Dekken, A J van Vuuren, W A Bode, H van der Valk, R J T Ouwendijk, R Giard, W Lesterhuis, R Heinhuis, E C Klinkenberg, G A Meijer, ter F Borg, J W Arends, J J Kolkman, J van Baarlen, R A de Vries, A H Mulder, A J P van Tilburg, G J A Offerhaus, F J W ten Kate, J G Kusters, E J Kuipers & P D Siersema. (2011) Predictors for Neoplastic Progression in Patients With Barrett's Esophagus: A Prospective Cohort Study. American Journal of Gastroenterology 106:7, pages 1231-1238.
Crossref
Crossref
Tusar K. Desai & Niharika Samala. (2011) The Incidence of Esophageal Adenocarcinoma Among Patients With Nondysplastic Barrett's Esophagus Has Been Overestimated. Clinical Gastroenterology and Hepatology 9:4, pages 363-364.
Crossref
Crossref
Anouk van de Winkel, Katinka P M van Zoest, Herman van Dekken, Leon M G Moons, Ernst J Kuipers & Luc J W van der Laan. (2011) Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett’s oesophagus. Histopathology 58:2, pages 246-253.
Crossref
Crossref
Gloria Fernández-Esparrach & Antonio Rodríguez-D’Jesús. (2011) Radiofrecuencia en el tratamiento del esófago de Barrett. Gastroenterología y Hepatología 34:1, pages 35-40.
Crossref
Crossref
Shane Duggan, David Prichard, Murat Kirca & Dermot Kelleher. 2011. Inflammation and Gastrointestinal Cancers. Inflammation and Gastrointestinal Cancers
35
50
.
Marjolein Sikkema, Pieter J.F. de Jonge, Ewout W. Steyerberg & Ernst J. Kuipers. (2010) Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 8:3, pages 235-244.
Crossref
Crossref
Brian J. Reid, Xiaohong Li, Patricia C. Galipeau & Thomas L. Vaughan. (2010) Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nature Reviews Cancer 10:2, pages 87-101.
Crossref
Crossref
Pieter J F de Jonge, Mark van Blankenstein, Caspar W N Looman, Mariël K Casparie, Gerrit A Meijer & Ernst J Kuipers. (2010) Risk of Colorectal Cancer in Patients With Barrett's Esophagus: A Dutch Population-Based Study. American Journal of Gastroenterology 105:1, pages 77-83.
Crossref
Crossref
Ananya Das. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
745
770.e5
.
Michelle E Kruijshaar, Marie-Louise Essink-Bot, Bas Donkers, Caspar WN Looman, Peter D Siersema & Ewout W Steyerberg. (2009) A labelled discrete choice experiment adds realism to the choices presented: preferences for surveillance tests for Barrett esophagus. BMC Medical Research Methodology 9:1.
Crossref
Crossref
Tim Bright, Ann Schloithe, Jeff A. Bull, Robert J. Fraser, Peter Bampton & David I. Watson. (2009) Outcome of endoscopy surveillance for Barrett's oesophagus. ANZ Journal of Surgery 79:11, pages 812-816.
Crossref
Crossref
Marjolein Sikkema, Marjon Kerkhof, Ewout W Steyerberg, Johannes G Kusters, Paulina MH van Strien, Caspar WN Looman, Herman van Dekken, Peter D Siersema & Ernst J Kuipers. (2009) Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case–Control Study. The American Journal of Gastroenterology 104:11, pages 2673-2680.
Crossref
Crossref
Marco Rainer Kesting, Christian Schurr, Luisa Robitzky, Lars Steinstraesser, Markus Nieberler, Hansjörg Baurecht, Klaus-Dietrich Wolff, Denys John Loeffelbein & Thomas Mücke. (2009) Results of Esophagogastroduodenoscopy in Patients With Oral Squamous Cell Carcinoma—Value of Endoscopic Screening: 10-Year Experience. Journal of Oral and Maxillofacial Surgery 67:8, pages 1649-1655.
Crossref
Crossref
Nicholas J. Shaheen & Lena B. Palmer. (2009) Improving Screening Practices for Barrett's Esophagus. Surgical Oncology Clinics of North America 18:3, pages 423-437.
Crossref
Crossref
Gary W. Falk. (2009) Risk Factors for Esophageal Cancer Development. Surgical Oncology Clinics of North America 18:3, pages 469-485.
Crossref
Crossref
John M. Inadomi, Ma Somsouk, Ryan D. Madanick, Jennifer P. Thomas & Nicholas J. Shaheen. (2009) A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus. Gastroenterology 136:7, pages 2101-2114.e6.
Crossref
Crossref
A. H. Hölscher, D. Vallböhmer, C. Gutschow & E. Bollschweiler. (2008) Reflux esophagitis, high-grade neoplasia, and early Barrett’s carcinoma—what is the place of the Merendino procedure?. Langenbeck's Archives of Surgery 394:3, pages 417-424.
Crossref
Crossref
Sachin Wani, Srinivas R Puli, Nicholas J Shaheen, Brenda Westhoff, Sanjeev Slehria, Ajay Bansal, Amit Rastogi, Hari Sayana & Prateek Sharma. (2009) Esophageal Adenocarcinoma in Barrett's Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review. The American Journal of Gastroenterology 104:2, pages 502-513.
Crossref
Crossref
Gary W. Falk. 2009. Endoscopic Therapy for Barrett's Esophagus. Endoscopic Therapy for Barrett's Esophagus
63
89
.
Zhe Jin, Yulan Cheng, Alexandru Olaru, Takatsugu Kan, Jian Yang, Bogdan Paun, Tetsuo Ito, James P. Hamilton, Stefan David, Rachana Agarwal, Florin M. Selaru, Fumiaki Sato, John M. Abraham, David G. Beer, Yuriko Mori, Yutaka Shimada & Stephen J. Meltzer. (2008) Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors. International Journal of Cancer 123:10, pages 2331-2336.
Crossref
Crossref
J. W. P. M. van Baal, A. M. Rygiel, F. Milano, M. Anderson, J. J. G. H. M. Bergman, C. A. Spek, K. K. Wang, M. P. Peppelenbosch & K. K. Krishnadath. (2008) Gene expression profile comparison of Barrett's esophagus epithelial cell cultures and biopsies. Diseases of the Esophagus 21:7, pages 628-633.
Crossref
Crossref
Fouad Yousef, Chris Cardwell, Marie M. Cantwell, Karen Galway, Brian T. Johnston & Liam Murray. (2008) The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-Analysis. American Journal of Epidemiology 168:3, pages 237-249.
Crossref
Crossref
Oksana Anand, Sachin Wani & Prateek Sharma. (2008) When and how to grade Barrett's columnar metaplasia: The Prague system. Best Practice & Research Clinical Gastroenterology 22:4, pages 661-669.
Crossref
Crossref
E. M. VAN SOEST, J. P. DIELEMAN, M. C. J. M. STURKENBOOM, P. D. SIERSEMA & E. J. KUIPERS. (2008) Gastro-oesophageal reflux, medical resource utilization and upper gastrointestinal endoscopy in patients at risk of oesophageal adenocarcinoma. Alimentary Pharmacology & Therapeutics 28:1, pages 137-143.
Crossref
Crossref
J K R Boult, P Tanière, M T Hallissey, M J Campbell & C Tselepis. (2008) Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network. British Journal of Cancer 98:12, pages 1985-1992.
Crossref
Crossref
L.M.G. Moons, J.G. Kusters, J.H.M. van Delft, E.J. Kuipers, R. Gottschalk, H. Geldof, W.A. Bode, J. Stoof, A.H.M. van Vliet, H.B. Ketelslegers, J.C.S. Kleinjans & P.D. Siersema. (2008) A pro-inflammatory genotype predisposes to Barrett's esophagus. Carcinogenesis 29:5, pages 926-931.
Crossref
Crossref
Waqar A. Qureshi, Justin Wu, Daniel DeMarco, Suhaib Abudayyeh & David Y. Graham. (2008) Capsule Endoscopy for Screening for Short-Segment Barrett's Esophagus. The American Journal of Gastroenterology 103:3, pages 533-537.
Crossref
Crossref
Jessica Boult, Keith Roberts, Matthew J. Brookes, Sharon Hughes, Jonathan P. Bury, Simon S. Cross, Gregory J. Anderson, Robert Spychal, Tariq Iqbal & Chris Tselepis. (2008) Overexpression of Cellular Iron Import Proteins Is Associated with Malignant Progression of Esophageal Adenocarcinoma. Clinical Cancer Research 14:2, pages 379-387.
Crossref
Crossref
Zhe Jin, James P. Hamilton, Jian Yang, Yuriko Mori, Alexandru Olaru, Fumiaki Sato, Tetsuo Ito, Takatsugu Kan, Yulan Cheng, Bogdan Paun, Stefan David, David G. Beer, Rachana Agarwal, John M. Abraham & Stephen J. Meltzer. (2008)
Hypermethylation of the
AKAP12
Promoter is a Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
. Cancer Epidemiology, Biomarkers & Prevention 17:1, pages 111-117.
Crossref
Crossref
Peter M Irving, Fergus Shanahan & David S Rampton. (2008) Drug Interactions in Inflammatory Bowel Disease. The American Journal of Gastroenterology 103:1, pages 207-219.
Crossref
Crossref
Zhe Jin, Yuriko Mori, James P. Hamilton, Alexandru Olaru, Fumiaki Sato, Jian Yang, Tetsuo Ito, Takatsugu Kan, Rachana Agarwal & Stephen J. Meltzer. (2007) Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis. Cancer 112:1, pages 43-49.
Crossref
Crossref
T. THOMAS, K. R. ABRAMS, J. S. DE CAESTECKER & R. J. ROBINSON. (2007) Meta analysis: cancer risk in Barrett’s oesophagus. Alimentary Pharmacology & Therapeutics 26:11-12, pages 1465-1477.
Crossref
Crossref
Zhe Jin, Alexandru Olaru, Jian Yang, Fumiaki Sato, Yulan Cheng, Takatsugu Kan, Yuriko Mori, Carmit Mantzur, Bogdan Paun, James P. Hamilton, Tetsuo Ito, Suna Wang, Stefan David, Rachana Agarwal, David G. Beer, John M. Abraham & Stephen J. Meltzer. (2007) Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer. Clinical Cancer Research 13:21, pages 6293-6300.
Crossref
Crossref
Marie-Louise Essink-Bot, Michelle E. Kruijshaar, Dirk J. Bac, Pieter J. Wismans, Frank ter Borg, Ewout W. Steyerberg & Peter D. Siersema. (2007) Different perceptions of the burden of upper GI endoscopy: an empirical study in three patient groups. Quality of Life Research 16:8, pages 1309-1318.
Crossref
Crossref
Z Jin, Y Mori, J Yang, F Sato, T Ito, Y Cheng, B Paun, J P Hamilton, T Kan, A Olaru, S David, R Agarwal, J M Abraham, D Beer, E Montgomery & S J Meltzer. (2007) Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. Oncogene 26:43, pages 6332-6340.
Crossref
Crossref
San Ren LIN, Guo Ming XU, Pin Jin HU, Li Ya ZHOU, Min Hu CHEN, Mei Yun KE, Yao Zong YUAN, Dian Chun FANG & Shu Dong XIAO. (2007) Chinese consensus on gastroesophageal reflux disease (GERD): October 2006, Sanya, Hainan Province, China. Journal of Digestive Diseases 8:3, pages 162-169.
Crossref
Crossref
Eugene Y. Chang, Cynthia D. Morris, Ann K. Seltman, Robert W. O'Rourke, Benjamin K. Chan, John G. Hunter & Blair A. Jobe. (2007) The Effect of Antireflux Surgery on Esophageal Carcinogenesis in Patients With Barrett Esophagus. Annals of Surgery 246:1, pages 11-21.
Crossref
Crossref
M Kerkhof, H van Dekken, E W Steyerberg, G A Meijer, A H Mulder, A de Bruïne, A Driessen, F J ten Kate, J G Kusters, E J Kuipers & P D Siersema. (2007) Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 50:7, pages 920-927.
Crossref
Crossref
James P. Hamilton, Fumiaki Sato, Zhe Jin, Bruce D. Greenwald, Tetsuo Ito, Yuriko Mori, Bogdan C. Paun, Takatsugu Kan, Yulan Cheng, Suna Wang, Jian Yang, John M. Abraham & Stephen J. Meltzer. (2006)
Reprimo
Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
. Clinical Cancer Research 12:22, pages 6637-6642.
Crossref
Crossref
Pieter J F de Jonge, Ewout W Steyerberg, Ernst J Kuipers, Pieter Honkoop, Leonieke M M Wolters, Marjon Kerkhof, Horman van Dekken & Peter D Siersema. (2006) Risk Factors for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus. The American Journal of Gastroenterology 101:7, pages 1421-1429.
Crossref
Crossref
M. FULLARD, J. Y. KANG, P. NEILD, A. POULLIS & J. D. MAXWELL. (2006) Systematic review: does gastro-oesophageal reflux disease progress?. Alimentary Pharmacology and Therapeutics 24:1, pages 33-45.
Crossref
Crossref
M. Hage, P.D. Siersema & H. van Dekken. (2006) Oesophageal pathology following ablation of Barrett's mucosa. Current Diagnostic Pathology 12:2, pages 127-135.
Crossref
Crossref
Mariska Hage, Peter D. Siersema, Kees J. Vissers, Winand N.M. Dinjens, Ewout W. Steyerberg, Jelle Haringsma, Ernst J. Kuipers & Herman van Dekken. (2005) Genomic analysis of Barrett's esophagus after ablative therapy: Persistence of genetic alterations at tumor suppressor loci. International Journal of Cancer 118:1, pages 155-160.
Crossref
Crossref
Jukka Ronkainen, Pertti Aro, Tom Storskrubb, Sven–Erik Johansson, Tore Lind, Elisabeth Bolling–Sternevald, Michael Vieth, Manfred Stolte, Nicholas J. Talley & Lars Agréus. (2005) Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study. Gastroenterology 129:6, pages 1825-1831.
Crossref
Crossref
Gerard Isenberg, Michael V. SivakJr.Jr., Amitabh Chak, Richard C.K. Wong, Joseph E. Willis, Brian Wolf, Douglas Y. Rowland, Ananya Das & Andrew Rollins. (2005) Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study. Gastrointestinal Endoscopy 62:6, pages 825-831.
Crossref
Crossref
Leon MG Moons, Johannes G Kusters, Evelien Bultman, Ernst J Kuipers, Herman van Dekken, Wendy MW Tra, Alex Kleinjan, Jaap Kwekkeboom, Arnoud HM van Vliet & Peter D Siersema. (2005) Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. The Journal of Pathology 207:3, pages 269-276.
Crossref
Crossref
Peter D. Siersema. (2005) Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventions. Gastrointestinal Endoscopy 62:4, pages 503-507.
Crossref
Crossref